Form D · Private Equity Fund

Apogem Secondary Fund VII (Cayman), LP

New York, NY · CIK 0002030606

Offering snapshot reported Jul 17, 2025 · SEC filing

Reported sold: $255M
Investors reported: 145
Minimum accepted: $1M
First sale: Jul 2, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$60,525,000 → $254,825,000
Reported investors16 → 145

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 17, 2025	Amendment	$254,825,000	$194,300,000vs Jul 19, 2024	145	SEC filing
Jul 19, 2024	Initial	$60,525,000	No comparison	16	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-519267

Amount sold includes sales in US and non-US

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
NY Life Distributors LLC	35350
Alvine Capital Management Limited	None
Alvine Capital AB (ABCAB)	None

Source: Form D, filed Jul 17, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Apogem Capital Llc	Promoter
N/A Asf Vii Gp, Llc	Director
John M Grady	Executive
Michael Greich	Executive
Christopher Stringer	Executive
Michael Zeleniuch	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

299 Park Avenue 37 Th Floor
New York, NY, 10171